Skip to main content

Nasdaq IPOs

Cell therapy biotech Longeveron sets terms for $25 million IPO

5 years 8 months ago
Longeveron, a Phase 2 biotech developing cellular therapies for aging-related conditions, announced terms for its IPO on Wednesday. The Miami, FL-based company plans to raise $25 million by offering 2.3 million shares at a price range of $10 to $12. At the midpoint of the propos
Renaissance Capital

Chinese cancer biotech Adagene sets terms for $132 million US IPO

5 years 8 months ago
Adagene, a Phase 1 biotech developing antibody cancer immunotherapies in China, announced terms for its US IPO on Wednesday. The Suzhou, China-based company plans to raise $132 million by offering 7.4 million ADSs at a price range of $17 to $19. At the midpoint of the proposed r
Renaissance Capital

February starts off with the busiest week for US IPOs in over a decade

5 years 8 months ago
16 IPOs are set to make this the busiest week for the US IPO market since December 2006. Driven by faster IPO timelines and momentum from last year, 2021 is positioning itself to be a banner year for the IPO market, and this latest milestone joins a growing list. Already, the US
Renaissance Capital

Cannabis finance REIT AFC Gamma sets terms for $100 million IPO

5 years 8 months ago
AFC Gamma, a newly-formed commercial mortgage REIT focused on the cannabis industry, announced terms for its IPO on Wednesday. The West Palm Beach, FL-based company plans to raise $100 million by offering 5.6 million shares at a price range of $17 to $19. At the midpoint of the
Renaissance Capital

Virtual communication platform ON24 prices IPO at $50 high end

5 years 8 months ago
ON24, which provides a B2B customer engagement platform supporting webinars and analytics, raised $428 million by offering 8.6 million shares (26% secondary) at $50, the high end of the range of $45 to $50. New investor Tiger Global Management had indicated on $75 million wo
Renaissance Capital

Financials SPAC Finserv Acquisition II files for a $250 million IPO

5 years 8 months ago
Finserv Acquisition II, the second blank check company led by finance veterans targeting the fintech industry, filed on Tuesday with the SEC to raise up to $250 million in an initial public offering. The New York, NY-based company plans to raise $250 million by offering 25 milli
Renaissance Capital

French biotech Biophytis sets terms for $20 million US IPO

5 years 8 months ago
Biophytis, a French Phase 2 biotech developing therapies for COVID-related complications and age-related diseases, announced terms for its IPO on Tuesday. The company is currently listed on the Euronext Growth Paris (ALBPS). It previously filed to raise $15 million in t
Renaissance Capital

Tech-focused SPAC Agile Growth files for a $300 million IPO

5 years 8 months ago
Agile Growth, a blank check company targeting technology, filed on Tuesday with the SEC to raise up to $300 million in an initial public offering. The Newton, MA-based company plans to raise $300 million by offering 30 million units at $10. Each unit will consist of one share of
Renaissance Capital
Checked
12 minutes 51 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed